SEC Form 4 · accession 0001102624-15-000100
Boston Therapeutics, Inc. · BTHE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Platt
Officer — CEO and Chairman · Director · 10% Owner
Period of report
Jan 23, 2015
Accepted (ET)
Jan 27, 2015 · 3:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001473579
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 23, 2015 | P | 500 | $0.40 | A | 7,544,085 | D |
Table II — derivative securities
No Table II lines on this filing.